AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS

Study Overview
=================
Brief Summary
-----------------
Aim of the study is to evaluate the prevalence and bring awareness ofcardiovascular complications in COVID-19 recovered patients. Study is conducted at single site, which is Srinivasa Heart Centre, Warangal, Telangana state in India for the duration of 4 months. The sample size is calculated 500 patients and the study is cohort, observational study. Patient consent has been taken before enrolment.

Detailed Description
-----------------
The aim of the study is to evaluate the prevalence and bring awareness of cardiovascular complications in COVID-19 recovered patients. Objectives of the study: To study causes and risk factors of cardiac disorders associated with COVID-19 To identify different types of cardiac symptoms patients, present with To study the impact of co-morbidities on COVID-19 recovered patients To study treatment patterns and duration of therapy Plan to study: To select the patient based on inclusion and exclusion criteria To collect the patient information from case sheets and by patient interaction To identify different types of cardiac disorders related to COVID-19 or its treatment regimen To study the management of COVID-19 complication and related cardiovascular disorders Study Sites: Srinivasa Heart Centre, Warangal (T.S) Study Design: Observational cohort study Study Duration: 4 months Subject Eligibility: Inclusion Criteria Patients who are willing to participate Patients having previous COVID-19 treatment record Prescriptions reported during the study period The prescription which is legible and complete Exclusion Criteria Patients who are not willing to participate The patient having no history of COVID-19 and available data Source of the data: Review of patient case sheet, prescription and lab reports Personal interaction with patients and caregivers Sample size: 500 Patients

Official Title
-----------------
AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS

Conditions
-----------------
Gender Discrimination, Cardiac Event, Complication

Intervention / Treatment
-----------------
* Behavioral: Difference in gender, response to disease, diagnostic test values


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients who are willing to participate Patients having previous COVID-19 treatment record Prescriptions reported during the study period The prescription which is legible and complete Exclusion Criteria: Patients who are not willing to participate The patient having no history of COVID-19 and available data

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 100 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| All population<br>The total population reported to Cardiology department during enrollment period | Behavioral: Difference in gender, response to disease, diagnostic test values<br>* Gender difference: Prevalence of disease in male vs female Response to disease: Which group is more prone to cardiac involvement Diagnostic tests: Diagnostic confirmation of disease<br>|
| COVID recovered<br>Patient having history of COVID 19 disease | Behavioral: Difference in gender, response to disease, diagnostic test values<br>* Gender difference: Prevalence of disease in male vs female Response to disease: Which group is more prone to cardiac involvement Diagnostic tests: Diagnostic confirmation of disease<br>|
| No history of COVID<br>Population those who never exposed to COVID 19 disease and never suffers | Behavioral: Difference in gender, response to disease, diagnostic test values<br>* Gender difference: Prevalence of disease in male vs female Response to disease: Which group is more prone to cardiac involvement Diagnostic tests: Diagnostic confirmation of disease<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| ECG, Lipid profile, TMT, and 2D Echo | The following tests are performed to every individuals and relevant report are considered | September 2021 to February 2022 | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Cardiovascular involvement, COVID 19 disease, Gender difference